AVITA MEDICAL INC (RCEL)
US05380C1027 - Common Stock
AVITA Medical to Announce First Quarter 2024 Financial Results
AVITA Medical to Announce First Quarter 2024 Financial Results
AVITA Medical will report first quarter 2024 financial results after the close on May 13, 2024, and host a webcast that day at 1:30 p.m. Pacific Time. ...
Notable Thursday Option Activity: RCEL, MRVL, DAL
AVITA Medical Updates Expected First Quarter 2024 Revenue
AVITA Medical Updates Expected First Quarter 2024 Revenue
AVITA Medical updates expected Q1 2024 commercial revenue; reaffirms expectations for full-year 2024 revenue at lower end of previously provided guidance....
AVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA Supplement
AVITA Medical Submits Response to FDA, Resuming Review Clock for RECELL GO PMA Supplement
AVITA Medical submitted its response to FDA for additional information in connection to RECELL GO PMA supplement. Submission resumes substantive review....
AVITA Medical to Present at TD Cowen 44th Annual Health Care Conference
AVITA Medical to Present at TD Cowen 44th Annual Health Care Conference
AVITA Medical to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024, at 9:50 a.m. Eastern Time....
AVITA Medical to Host Investor Webinar Briefing
AVITA Medical to Host Investor Webinar Briefing
AVITA Medical to host investor webinar briefing on February 27, 2024, at 2:00 p.m. PST. ...
AVITA Medical Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance
AVITA Medical Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance
AVITA Medical reports fourth quarter and full-year 2023 financial results....
Commit To Purchase AVITA Medical At $15, Earn 14.4% Annualized Using Options
AVITA Medical to Announce Fourth Quarter and Full Year 2023 Financial Results
AVITA Medical to Announce Fourth Quarter and Full Year 2023 Financial Results
AVITA Medical to announce fourth quarter and full year 2023 financial results on February 22, 2024, at 1:30 p.m. Pacific Time. ...
Cantor picks RCEL as best 2024 medtech idea; bullish on PACB, AXGN, CERS
Cantor Fitzgerald picks AVITA Medical (RCEL) as its best 2024 medtech idea, while remaining bullish on AXGN, CERS, ELUT, XGN, NNOX, NPCE, NYXH, SIBN, and PACB. Read more here.
AVITA Medical Announces Exclusive Distribution Agreement with Stedical Scientific
AVITA Medical Announces Exclusive Distribution Agreement with Stedical Scientific
AVITA Medical announced exclusive multi-year distribution agreement with Stedical Scientific, Inc. to commercialize PermeaDerm in the United States....
Avita Medical misses Q4,FY 23 prelim revenue estimate (NASDAQ:RCEL)
Avita Medical reports lower-than-expected commercial revenue for Q4 and FY 2023, with growth projections falling short for Q1 2024 and FY 2024.
AVITA Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
AVITA Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
AVITA Medical to present at JP Morgan's Annual Healthcare Conference in San Francisco on Thursday, January 11, 2024. ...
Bullish Two Hundred Day Moving Average Cross - RCEL
AVITA Medical to Host Investor Webinar Briefing
AVITA Medical to Host Investor Webinar Briefing
AVITA Medical to host investor webinar briefing on December 5, 2023, at 2:00 p.m. PST. Register at https://rebrand.ly/Dec2023webinar...
AVITA Medical to Present at the Piper Sandler 35th Annual Healthcare Conference
AVITA Medical to Present at the Piper Sandler 35th Annual Healthcare Conference
VALENCIA, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading...